glp-1 patient education pdf Anti-obesity drugs for the gastroenterologist GLP-1 Side Effects: Tips +

Saxenda: Daily Injections with a Different Ingredient Saxenda (liraglutide 3.0 mg) is also a GLP-1 receptor agonist, but it uses a different active compound liraglutide instead of semaglutide

Peminda Cabandugama, MD, an endocrinologist and obesity medicine specialist at Cleveland Clinic in Ohio, found the results to be slightly surprising. The pharmacokinetics [how drugs move through the body] of GLP-1 medications show a half-life of 5 days, which means the current standard of using these medications every 7 days is also stretching this out, says Dr

According to recent complaints, patients developed non arteritic anterior ischemic optic neuropathy, or NAION, after using the semaglutide based medications

doi:10.1210/jc.2014-1742

The FDA has also approved two GLP-1 diabetes drugs, Bydureon BCISE and Trulicity, for patients 10 y age and older